Frankie's will feature a full bar, country music and barbecue served from the Francis Bogside kitchen ... Mahoney Bar Group also owns San Antonio staples George's Keep, Hanzo and Lilly's Greenville.

Because nothing is worse than opening an empty kitchen cabinet when you're jonesing for a snack. View Entire Post › ...

This year marks the 200th anniversary of Our Lady’s Church, Carbally. Records show that a plot of land was donated by Lord ...

Shortly after a positive data drop for Eli Lilly’s efsitora alfa, the Indianapolis-based company is again padding the case for its weekly insulin prospect. Tuesday, Lilly revealed that efsitora ...

Three months on, Eli Lilly has closed the books on its search for a new chief financial officer. And as with its previous CFO, Anat Ashkenazi, the company didn’t have to look far. Lilly on ...

From STAT’s Elaine Chen: Eli Lilly reported more data on its weekly insulin, efsitora alfa. In a Phase 3 trial of type 1 patients, the drug met the primary endpoint of non-inferior A1C ...

Share on Pinterest Eli Lilly’s once-weekly insulin injection is as effective as daily shots for managing blood sugar in diabetes, new data shows. Scott Olson/Getty Images New research offers an ...

Eli Lilly (NYSE: LLY) stands atop the biopharmaceutical world. It's the biggest drugmaker by far based on market cap. Lilly's share price has skyrocketed nearly 700% over the last five years and ...

Drugmaker Eli Lilly named Lucas Montarce as chief financial officer, filling a vacancy left by the departure of Anat Ashkenazi, who joined Google’s parent company Alphabet as CFO earlier this year.

Eli Lilly said a once-weekly dose of insulin efsitora proved to reduce hemoglobin A1C in a Qwint-2 Phase 3 trial when compared with a daily dose of insulin in people with type 2 diabetes using ...

Eli Lilly has three likely blockbuster drugs that are relatively new to the market. Its pipeline features three other late-stage candidates with blockbuster potential. Lilly's long-term growth ...

28 analysts have shared their evaluations of Eli Lilly LLY during the recent three months, expressing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table ...